| BMD testing | OP Treatment | ||
---|---|---|---|---|
Covariates | Crude OR | Adjusted OR (95% CI) | Crude OR | Adjusted OR (95% CI) |
Age in years | Â | Â | Â | Â |
65–69 | 1.00 | - | 1.00 | - |
70–74 | 0.71 | 0.79 (0.70; 0.89) *** | 0.89 | 0.97 (0.85; 0.89 1.10) |
75–79 | 0.42 | 0.52 (0.46; 0.59) *** | 0.70 | 0.86 (0.76; 0.98) * |
≥80 | 0.11 | 0.17 (0.15; 0.20) *** | 0.40 | 0.60 (0.53; 0.67)*** |
Fracture | Â | Â | Â | Â |
Hip | 1.00 | - | 1.00 | - |
Humerus | 2.14 | 1.42 (1.26; 1.60)*** | 1.25 | 1.00 (0.90; 1.11) |
Wrist | 3.16 | 1.83 (1.62; 2.07) *** | 1.52 | 1.18 (1.06; 1.32) * |
Vertebral | 2.17 | 2.09 (1.83; 2.38) *** | 4.69 | 4.22 (3.80; 4.69) *** |
Social status § |  |  |  |  |
At home with no IS | 1.00 | - | 1.00 | - |
At home with partial IS | 0.59 | 0.73 (0.67; 0.81)*** | 1.03 | 1.12 (1.03; 1.21) * |
At home with max IS | 0.31 | 0.46 (0.37; 0.56)*** | 0.76 | 0.93 (0.81; 1.07) |
Living in LTCF | 0.02 | 0.04 (0.02; 0.10)*** | - | - |
Comorbidity index | 0.99 | 0.98 (0.97; 0.99) *** | 1.07 | 1.02 (1.01; 1.03)*** |
Prior BMD testing | 4.80 | 2.45 (2.16; 2.79)*** | 6.19 | 2.10 (1.82; 2.42)*** |
Prior OP treatment | 2.45 | 1.51 (1.35; 1.68)*** | 16.8 | 13.6 (12.4; 15.0)*** |
Long-term glucocorticoid use | 1.15 | 0.97 (0.71; 1.31) | 3.93 | 1.45 (1.12; 1.89) * |
Distance from BMD device | Â | Â | Â | Â |
≤ 32 km | 1.00 | - | - | - |
Between 32 and 64 km | 0.68 | 0.75 (0.62; 0.91) * | Â | Â |
Between 64 and 105 km | 0.36 | 0.36 (0.25; 0.52)*** | Â | Â |
More than 105 km | 0.26 | 0.28 (0.19; 0.40)*** | Â | Â |